Vigilant Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $194K | Hold |
550
| – | – | 0.01% | 152 |
|
|
2023
Q1 | $173K | Hold |
550
| – | – | 0.01% | 153 |
|
|
2022
Q4 | $159K | Hold |
550
| – | – | 0.01% | 164 |
|
|
2022
Q3 | $159K | Hold |
550
| – | – | 0.01% | 166 |
|
|
2022
Q2 | $155K | Hold |
550
| – | – | 0.01% | 175 |
|
|
2022
Q1 | $144K | Sell |
550
-450
| -45% | -$118K | 0.01% | 204 |
|
|
2021
Q4 | $220K | Sell |
1,000
-61
| -6% | -$13.4K | 0.02% | 185 |
|
|
2021
Q3 | $192K | Sell |
1,061
-550
| -34% | -$99.5K | 0.02% | 158 |
|
|
2021
Q2 | $325K | Sell |
1,611
-89
| -5% | -$18K | 0.03% | 121 |
|
|
2021
Q1 | $365K | Sell |
1,700
-400
| -19% | -$85.9K | 0.03% | 97 |
|
|
2020
Q4 | $496K | Sell |
2,100
-669
| -24% | -$158K | 0.05% | 75 |
|
|
2020
Q3 | $754K | Buy |
2,769
+2,700
| +3,913% | +$735K | 0.08% | 59 |
|
|
2020
Q2 | $20K | Hold |
69
| – | – | ﹤0.01% | 251 |
|
|
2020
Q1 | $16K | Buy |
+69
| New | +$16K | ﹤0.01% | 266 |
|
|
2019
Q3 | – | Sell |
-16
| Closed | -$3K | – | 427 |
|
|
2019
Q2 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 370 |
|
|
2016
Q4 | – | Sell |
-251
| Closed | -$22K | – | 297 |
|
|
2016
Q3 | $22K | Hold |
251
| – | – | ﹤0.01% | 225 |
|
|
2016
Q2 | $22K | Buy |
+251
| New | +$22K | ﹤0.01% | 219 |
|
|
2015
Q4 | – | Sell |
-200
| Closed | -$21K | – | 287 |
|
|
2015
Q3 | $21K | Buy |
+200
| New | +$21K | ﹤0.01% | 207 |
|
|
2014
Q1 | – | Sell |
-200
| Closed | -$15K | – | 289 |
|
|
2013
Q4 | $15K | Buy |
+200
| New | +$15K | ﹤0.01% | 211 |
|